To access this element change to forms mode OFF
Grant Award View - GA58648-V2
Development of novel dietary supplementtargeting gut health
GA ID:
GA58648-V2
Agency:
Department of Industry, Science and Resources
Approval Date:
10-Jul-2019
Variation Publish Date:
10-Nov-2021
Variation Date:
7-Nov-2021
Category:
Business Development
Grant Term:
17-Sep-2019 to 26-Feb-2027
Value (AUD):
$656,089.50
(GST inclusive where applicable)
Varies:
GA58648
- Development of novel dietary supplementtargeting gut health
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
DISR 19/20 Growing innovative & competitive bus, industries & regions
Grant Program:
Entrepreneurs' Programme – Accelerating Commercialisation
Grant Activity:
Development of novel dietary supplementtargeting gut health
Purpose:
Vernx has developed a soft gel capsule containing branched chain fatty acids which are naturally found in vernix caseosa and breast milk that will help improve gut health. Accelerating Commercialisation support will be used to help Vernx commercialise branched chain fatty acid product in the dietary supplement market and achieve first sales in Australia which will ultimately set the company up for a global expansion.
GO ID:
GO Title:
Entrepreneurs' Programme - Accelerating Commercialisation
Internal Reference ID:
AC76647
Selection Process:
Open Competitive
Confidentiality - Contract:
No
Confidentiality - Outputs:
No
Grant Recipient Details
Recipient Name:
VERNX BIOTECHNOLOGY PTY LTD
Recipient ABN:
93 609 495 294
Grant Recipient Location
Suburb:
SOUTHBANK
Town/City:
Southbank
Postcode:
3066
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
VIC
Postcode:
3006
Country:
AUSTRALIA